Vertex Pharmaceuticals A second Nasdaq 100 stock that's begging to be bought in February is biotech stock Vertex Pharmaceuticals (NASDAQ: VRTX). Where this company has really made its presence known is in treating people with cystic fibrosis (CF), a genetic disease characterized by thick mucus production that can obstruct a patient's lungs and/or pancreas. Although historically high inflation threatens to reduce the discretionary purchasing power of low-earning workers, PayPal's digital payment networks have demonstrated incredible operating resilience.